From: Cardiovascular protection of magnolol: cell-type specificity and dose-related effects
Dosage | Effect | Reference |
---|---|---|
Low (10 -7~ 10 -4  mg/kg) | ||
10-7~−6 mg/kg (i.v.) | Prevent post MI‒induced ventricular arrythmia | |
10-5 mg/kg (i.v.) | Decrease MI‒induced infarct size | [16] |
Moderate (10 -4~ 10 -2  mg/kg) | ||
10-4~−3 mg/kg (i.v.) | Protect myocardium against MI‒induced myocardial wall thinning | [19] |
2-5 × 10-4 mg/kg (i.v.) | Decrease neutrophil infiltration in infarct heart | [20] |
10-3 mg/kg (i.m.) daily | Attenuate balloon‒induced intimal thickening and inhibit LDL oxidation | [24] |
10-3 mg/kg (i.m.) daily | Attenuate hypercholesteremia‒induced intimal thickening, TNFα and VCAM‒1 elevation in an aorta. | [40] |
High (≧10 -1  mg/kg) | ||
10-1 mg/kg (i.v.) | Reduce coronary artery resistance after MI | [21] |
10 mg/kg (i.p.) | Prevent MI‒induced cardiomyocyte apoptosis | [22] |